Stay updated with breaking news from Kezar Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avidity Partners Management LP trimmed its position in Kezar Life Sciences, Inc. (NASDAQ:KZR – Free Report) by 16.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,025,454 shares of the company’s stock after selling 985,646 shares during the quarter. Avidity Partners […]
Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the...
07.06.2024 - Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the Compensation Committee of the ...
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed on a Current Report on Form 8-K filed by...
Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that Chris...